All In MedTech

FDA Clearance Tracker · P180046-S076

Axonics Sacral Neuromodulation System

A PMA supplement is a change to a device that already has premarket approval, such as a new indication, a design change or a manufacturing change.

Last checked: Nov 20, 2026Latest source record: Feb 8, 2024 (this decision)Source: openFDAMethods & limitations

PMA supplement

The decision

FDA number
P180046-S076
Device name
Axonics Sacral Neuromodulation System
Applicant location
Marlborough, MA
Received
Nov 13, 2023
Decided
Feb 8, 2024
Decision
Approved
Supplement type
Normal 180 Day Track
Reason for supplement
Labeling Change - Indications/instructions/shelf life/tradename
Original approval
P180046

Device type

Device class
Class III
Regulation
21 CFR 876.5270

Every decision under product code EZW

FDA's approval statement

As written in FDA's record.

Approval of the expansion to 1.5T MRI conditional labeling for patients who have the Axonics Sacral Neuromodulation System with an existing Medtronic Sacral Neuromodulation lead fragment.

Source documents

Other decisions for Boston Scientific Corporation

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

7 more FDA decisions with a free account

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.